Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-03

Clinical Trial Update: Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22 [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated whether adding contingent reinforcement to buprenorphine-based behavioral treatment improves opioid and cocaine abstinence. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: University of Vermont | Conditions: Cocaine-Related Disorders, Opioid-Related Disorders | Phase 2 | Status: COMPLETED